NVOH Price Forecast & ETF Analysis. Dividend · Expense Ratio · Holdings · NAV · RSI · MACD

NVOH

Novo Nordisk A/S (B Shares) ADRhedged

At close Oct 30 at 2:59 PM ET (Korea 10/31 03:59)

$22.16

+0.48 ▲ +2.22%

Descending Triangle Resistance 24.54 Support 19.99 Holding Same lines for 2 days Lines drawn by AI for reference. They may be wrong. Treat them as a hint, not a forecast.

Full metrics table

Category ⓘ	Global or ExUS Equities - Industry Sector	Expense ⓘ	0.19%	Return% 1Y ⓘ	-20.25%	Total Holdings ⓘ	2	Perf Week ⓘ	-0.31%	Volume ⓘ	433
Asset Type ⓘ	Equities (Stocks)	AUM ⓘ	$4M	Return% 3Y ⓘ	-	NAV ⓘ	$21.77	Perf Month ⓘ	4.47%	Avg Volume ⓘ	0.00M
ETF Type ⓘ	Global Ex. US Equities	Dividend TTM ⓘ	$1.56 (7.04%)	Return% 5Y ⓘ	-	52W High ⓘ	-35.51%	Perf Quarter ⓘ	-12.78%	Rel Volume ⓘ	0.31
Active/Passive ⓘ	Active	Div Gr. 3/5Y ⓘ	-	Return% 10Y ⓘ	-	52W Low ⓘ	16.63%	Perf Half Y ⓘ	-4.4%	Prev Close ⓘ	$21.68
IPO ⓘ	2025/1/7	Flows% 1M ⓘ	0%	Return% SI ⓘ	-34.03%	RSI (14) ⓘ	50.67	Perf YTD ⓘ	-19.23%	Price ⓘ	$22.16
Beta ⓘ	1.44	Flows% 3M ⓘ	7.15%	Flows% YTD ⓘ	85.1%	Flows% 1Y ⓘ	310.94%	Perf Year ⓘ	-21.61%	Volatility(W/M) ⓘ	0.6% 1.65%
SMA20 ⓘ	1.9%	SMA50 ⓘ	-3.17%	SMA200 ⓘ	-8.47%	ATR ⓘ	0.41

About this ETF

Novo Nordisk A/S (B Shares) ADRhedgedNVOH | NYSE | Dividend income Deep dive

Novo Nordisk A/S (B Shares) ADRhedged seeks to provide investment results that correspond generally, before fees and expenses, to the total return of the ordinary shares of Novo Nordisk A/S (B Shares) in its local market. The series, under normal circumstances, invests at least 95% of its net assets in American Depositary Receipts ("ADRs") of the Novo Nordisk A/S (B Shares) (the "Company"). The series will not invest directly in the company. The fund is non-diversified.

NVOH at a glance

0.19% Lower is better

$4M Assets Under Management

7.04%

Listed 2025

Management Style Actively managed

Top Holdings 2 holdings

The top 3 make up 100% of the fund

Concentrated in a few names. When they swing, the ETF swings with them.